Botulinum toxin type A combined with neurodynamic mobilization for lower limb spasticity: A case report

Journal of Chiropractic Medicine

Volumn 12, Issue 1, 2013, Pages 39-44

  Villafañe, Jorge H ^a,b  

^a Residenza Sanitaria Assistenziale A Maritano   (Italy)

^b Private Practitioner   (Italy)

Author keywords

Botulinum toxin type A; Lower limb; Physiotherapy; Spasticity

Indexed keywords

EID: 84875789121     PISSN: 15563707     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcm.2013.01.001     Document Type: Article

References (37)

1. Zambelis T., Karandreas N., Tzavellas E., Kokotis P., Liappas J. Large and small fiber neuropathy in chronic alcohol-dependent subjects. J Peripher Nerv Syst 2005, 10(4):375-381.
2. Ammendola A., Tata M.R., Aurilio C., Ciccone G., Gemini D., Ammendola E., et al. Peripheral neuropathy in chronic alcoholism: a retrospective cross-sectional study in 76 subjects. Alcohol Alcohol 2001, 36(3):271-275.
3. Peters T.J., Kotowicz J., Nyka W., Kozubski W., Kuznetsov V., Vanderbist F., et al. Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial. Alcohol Alcohol 2006, 41(6):636-642.
4. Hyman N., Barnes M., Bhakta B., Cozens A., Bakheit M., Kreczy-Kleedorfer B., et al. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry 2000, 68(6):707-712.
5. Lim J.Y., Koh J.H., Paik N.J. Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. Stroke 2008, 39(1):126-131.
6. Yelnik A.P., Colle F.M., Bonan I.V., Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry 2007, 78(8):845-848.
7. Bhakta B.B., Cozens J.A., Bamford J.M., Chamberlain M.A. Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 1996, 61(1):30-35.
8. Kaji R., Osako Y., Suyama K., Maeda T., Uechi Y., Iwasaki M. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. J Neurol 2010, 257(8):1330-1337.
9. Simpson D.M., Alexander D.N., O'Brien C.F., Tagliati M., Aswad A.S., Leon J.M., et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996, 46(5):1306-1310.
10. Bakheit A.M., Thilmann A.F., Ward A.B., Poewe W., Wissel J., Muller J., et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000, 31(10):2402-2406.
11. Bhakta B.B., Cozens J.A., Chamberlain M.A., Bamford J.M. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 2000, 69(2):217-221.
12. McCrory P., Turner-Stokes L., Baguley I.J., De Graaff S., Katrak P., Sandanam J., et al. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. J Rehabil Med 2009, 41(7):536-544.
13. Prager E.M., Birkenmeier R.L., Lang C.E. Exploring expectations for upper-extremity motor treatment in people after stroke: a secondary analysis. Am J Occup Ther 2011, 65(4):437-444.
14. Rodgers H., Shaw L., Price C., van Wijck F., Barnes M., Graham L., et al. Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Trials 2008, 9:59.
15. Sun S.F., Hsu C.W., Hwang C.W., Hsu P.T., Wang J.L., Yang C.L. Application of combined botulinum toxin type A and modified constraint-induced movement therapy for an individual with chronic upper-extremity spasticity after stroke. Phys Ther 2006, 86(10):1387-1397.
16. Wolf S.L., Winstein C.J., Miller J.P., Taub E., Uswatte G., Morris D., et al. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 2006, 296(17):2095-2104.
17. Coppieters M.W., Butler D.S. Do 'sliders' slide and 'tensioners' tension? An analysis of neurodynamic techniques and considerations regarding their application. Man Ther 2008 Jun, 13(3):213-221.
18. Villafañe J.H., Silva G.B., Bishop M.D., Fernandez-Carnero J. Radial nerve mobilization decreases pain sensitivity and improves motor performance in patients with thumb carpometacarpal osteoarthritis: a randomized controlled trial. Arch Phys Med Rehabil 2012, 93(3):396-403.
19. Villafañe J.H., Silva G.B., Fernandez-Carnero J. Short-term effects of neurodynamic mobilization in 15 patients with secondary thumb carpometacarpal osteoarthritis. J Manipulative Physiol Ther 2011, 34(7):449-456.
20. Price D.D., Bush F.M., Long S., Harkins S.W. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 1994 Feb, 56(2):217-226.
21. Wood B.M., Nicholas M.K., Blyth F., Asghari A., Gibson S. Assessing pain in older people with persistent pain: the NRS is valid but only provides part of the picture. J Pain 2010, 11(12):1259-1266.
22. Kong K.H., Chua K.S., Lee J. Symptomatic upper limb spasticity in patients with chronic stroke attending a rehabilitation clinic: frequency, clinical correlates and predictors. J Rehabil Med 2010, 42(5):453-457.
23. Lundstrom E., Smits A., Terent A., Borg J. Time-course and determinants of spasticity during the first six months following first-ever stroke. J Rehabil Med 2010, 42(4):296-301.
24. Mykletun A., Stordal E., Dahl A.A. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry 2001, 179:540-544.
25. Snaith R.P. The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes 2003, 1:29.
26. Adrienne C., Manigandan C. Inpatient occupational therapists hand-splinting practice for clients with stroke: A cross-sectional survey from Ireland. J Neurosci Rural Pract 2011, 2(2):141-149.
27. Shacklock M. Clinical neurodynamics. Ed Elsevier. 2005.
28. Butler D, Jones M, Gore R. Mobilisation of the nervous system. Ed Churchill Livingstone. 1991.
29. Villafañe J.H., Silva G.B., Chiarotto A., Ragusa Orazio L.F. Botulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke. J Chiropr Med 2012, 11(3):186-191.
30. Villafañe J.H., Fernandez-de-las-Peñas C., Pillastrini P. Botulinum toxin type-A combined with manual therapy at the cervical spine for masseteric hypertrophy: a case report. J Chiropr Med 2012, 11(4):280-285.
31. Naicker A.S., Roohi S.A., Chan J.L. Botulinum toxin type A for rehabilitation after a spinal cord injury: a case report. J Orthop Surg (Hong Kong) 2009, 17(1):96-99.
32. Bertoni M., Castagna A., Baricich A., Berti G., Lazzaretti S., Morandi C. Administration of type A botulinum toxin after total hip replacement. Eur J Phys Rehabil Med 2008, 44(4):461-465.
33. Woelk H., Lehrl S., Bitsch R., Kopcke W. Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study. Alcohol Alcohol 1998, 33(6):631-638.
34. Stracke H., Lindemann A., Federlin K. A benfotiamine vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diabetes 1996, 104(4):311-316.
35. Haupt E., Ledermann H., Kopcke W. Benfotiamine in the treatment of diabetic polyneuropathy-a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 2005, 43(2):71-77.
36. Peters T.J., Kotowicz J., Nyka W., Kozubski W., Kuznetsov V., Vanderbist F., de Niet S., Marcereuil D., Coffiner M. Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial. Alcohol Alcohol 2006, 41(6):636-642.
37. Wright A. Hypoalgesia post-manipulative therapy: a review of a potential neurophysiological mechanism. Man Ther 1995 Nov, 1(1):11-16.